SCHEMBL7206659

SCHEMBL7206659

CCCN(CCC)CCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.58
TDP1 Q9NUW8 2/20 0.55
ALDH1A1 P00352 2/20 0.55
PRMT1 Q99873 2/20 0.54
HTT P42858 1/20 0.53
FFAR1 O14842 1/20 0.53
FFAR4 Q5NUL3 1/20 0.53
KDM4E B2RXH2 1/20 0.52
UCHL1 P09936 1/20 0.50
BACE1 P56817 1/20 0.49
MEN1 O00255 1/20 0.49
LMNA P02545 1/20 0.49
KMT2A Q03164 1/20 0.49
RORC P51449 1/20 0.48
AR P10275 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466084 0.87 FFAR1 (0.51) ALDH1A1FFAR1FFAR4UCHL1MEN1
Hydrochloric Acid SCHEMBL4914708 0.86 FFAR1 (0.50) ALDH1A1FFAR1FFAR4UCHL1MEN1
SCHEMBL24324833 0.86 CES1 (0.69) CES1TDP1ALDH1A1PRMT1HTT
SCHEMBL7207327 0.84 MEN1 (0.63) TDP1ALDH1A1HTTKDM4EMEN1
SCHEMBL27812546 0.83 FFAR1 (0.74) CES1TDP1ALDH1A1PRMT1HTT
SCHEMBL3027325 0.82 ALDH1A1 (0.49) ALDH1A1PRMT1LMNA
SCHEMBL7208101 0.80 PRMT1 (0.62) CES1TDP1ALDH1A1PRMT1HTT
SCHEMBL19234560 0.80 UCHL1 (0.76) CES1TDP1ALDH1A1PRMT1HTT
SCHEMBL6553107 0.80 UCHL1 (0.76) CES1TDP1ALDH1A1PRMT1HTT
Propane SCHEMBL7208109 0.80 HTR6 (0.67) CES1TDP1ALDH1A1PRMT1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077935-B1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS UPJOHN CO (US) 2003-10-29 EP claimed
EP-1077935-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 2001-02-28 EP claimed
US-6103766-A SUBSTITUTED OR UNSUBSTITUTED PHENYLSULFONAMIDE-PHENYLAMINE DERIVATIVES USEFUL FOR TREATING THE DISORDERS RELATED TO CENTRAL NERVOUS SYSTEM PHARMACIA & UPJOHN COMPANY (US) 2000-08-15 US claimed
WO-1999058499-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 1999-11-18 WO claimed
EP-1077935-B1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS UPJOHN CO (US) 2003-10-29 EP disclosed
EP-1077935-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 2001-02-28 EP disclosed
US-6103766-A SUBSTITUTED OR UNSUBSTITUTED PHENYLSULFONAMIDE-PHENYLAMINE DERIVATIVES USEFUL FOR TREATING THE DISORDERS RELATED TO CENTRAL NERVOUS SYSTEM PHARMACIA & UPJOHN COMPANY (US) 2000-08-15 US disclosed
WO-1999058499-A1 PHENYLSULFONAMIDE-PHENYLETHYLAMINES USEFUL AS DOPAMINE RECEPTORS PHARMACIA & UPJOHN COMPANY (US) 1999-11-18 WO disclosed